Shi-Xue Hu

Title: Shi-Xue Hu: Innovator in Tumor Suppressor Gene Research

Introduction

Shi-Xue Hu is a prominent inventor based in The Woodlands, TX (US). He has made significant contributions to the field of cancer research, particularly in the development of tumor suppressor genes and their applications in treating various forms of cancer. With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by abnormal cellular proliferation.

Latest Patents

Shi-Xue Hu's latest patents focus on broad-spectrum tumor suppressor genes and their gene products. One of his notable inventions relates to a broad-spectrum tumor suppressor gene and the protein expressed by that gene in appropriate host cells. This protein is identified as a second in-frame AUG codon-initiated retinoblastoma protein, with a relative molecular mass of about 94 kD. The invention also encompasses methods for treating mammals with diseases characterized by abnormal cellular proliferation, such as tumors or cancers. Treatment is achieved by inserting a host cell compatible p94.RB expression vector or an effective amount of p94.RB protein into the affected cells.

Career Highlights

Throughout his career, Shi-Xue Hu has worked with esteemed institutions, including Baylor College of Medicine. His research has been pivotal in advancing the understanding of tumor suppressor genes and their therapeutic applications. His innovative approaches have garnered attention in the scientific community.

Collaborations

Shi-Xue Hu has collaborated with notable colleagues, including Hong-Ji Xu and William F. Benedict. These partnerships have contributed to the advancement of research in the field of cancer treatment and gene therapy.

Conclusion

Shi-Xue Hu's work in the realm of tumor suppressor genes exemplifies the critical role of innovation in medical research. His contributions have the potential to lead to significant advancements in cancer treatment, ultimately benefiting countless patients.